share_log

泰恩康(301263.SZ):CKBA软膏II期临床方案完成受试者入组

Taikang (301263.SZ): The phase II clinical trial protocol of CKBA ointment has been completed for subject enrollment.

Zhitong Finance ·  Oct 31 06:17

Tiens (301263.SZ) announced that its wholly-owned subsidiary Jiangsu Bochuangyuan Biomedical Technology Co., Ltd. (referred to as Bochuangyuan)

Wisdom Financial APP News, Tiens (301263.SZ) announced that its wholly-owned subsidiary Jiangsu Bochuangyuan Biomedical Technology Co., Ltd. (referred to as Bochuangyuan) has organized the completion of all subjects in II phase clinical trial of innovative drug CKBA cream for the treatment of vitiligo indications according to the clinical trial plan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment